We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · October 04, 2020

Low Dose IL-2 for Treating Moderate to Severe Alopecia Areata

Journal of Investigative Dermatology


Additional Info

Journal of Investigative Dermatology
Low Dose IL-2 for Treating Moderate to Severe Alopecia Areata. A 52 Weeks Multicenter Prospective Placebo-Controlled Study Assessing Its Impact on T Regulatory Cells and Natural Killer Populations
J Invest Dermatol 2020 Sep 14;[EPub Ahead of Print], F Le Duff, JD Bouaziz, E Fontas, M Ticchioni, M Viguier, O Dereure, P Reygagne, H Montaudié, JP Lacour, S Monestier, MA Richard, T Passeron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading